Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers

11. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q3 2024: 56

Eli Lilly and Company (NYSE:LLY) has been one of the top-performing stocks on Wall Street over the past couple of years because of its weight loss medications. The shares are up by 16.4% year-over-year. Cramer has spent quite a bit of time discussing Eli Lilly and Company (NYSE:LLY) in January. He continues to support the firm despite the fact that year-to-date the stock is down by 6.7% as investors worry about weak guidance. Cramer believes that Eli Lilly and Company (NYSE:LLY)’s narrative will be driven by its drug approvals. His latest comments surrounded Medicare coverage extending to weight loss drugs:

“I think that there are a lot of people who felt that this had to happen. Uh, David Ricks, would be one of them, the CEO of Lilly. I think that you don’t have comorbidities with these and it’s going to be difficult. Otherwise they would, you know you talk about eight billion dollars, maybe for Novo, and Lilly’s drug is superior in terms of weight reduction at the same dose. No one thought that they would be able to just run amok. And I think that while the stocks are down, it’s going to be the greatest drug of all time. And everybody knows that. The persistence level of people who take it is much higher than what we’re hearing about. Drug and exercise, exercise has failed us. Diet has failed us. So drug is the way to make it so that people who can’t lose weight have to take it. But it’s not a shock. You go sell it, I don’t care.”